Invention Grant
- Patent Title: Halo-substituted piperidines as orexin receptor modulators
-
Application No.: US17116773Application Date: 2020-12-09
-
Publication No.: US11434236B2Publication Date: 2022-09-06
- Inventor: Theodore M. Kamenecka , Jörg Holenz , Steven Wesolowski , Yuanjun He , Roland Bürli
- Applicant: ASTRAZENECA AB , EOLAS THERAPEUTICS, INC.
- Applicant Address: SE Södertälje; US CA Carlsbad
- Assignee: ASTRAZENECA AB,EOLAS THERAPEUTICS, INC.
- Current Assignee: ASTRAZENECA AB,EOLAS THERAPEUTICS, INC.
- Current Assignee Address: SE Södertälje; US CA Carlsbad
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/4545 ; C07D417/14 ; C07D401/14 ; C07D409/14 ; C07D413/14 ; A61P25/34
Abstract:
The present application relates to certain halo-substituted piperidine compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating substance addiction, panic disorder, anxiety, post-traumatic stress disorder, pain, depression, seasonal affective disorder, an eating disorder, or hypertension.
Public/Granted literature
- US20210214348A1 HALO-SUBSTITUTED PIPERIDINES AS OREXIN RECEPTOR MODULATORS Public/Granted day:2021-07-15
Information query
IPC分类:
